{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:54:26Z","timestamp":1778352866475,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.arcmed.2007.04.006","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T07:22:43Z","timestamp":1182496963000},"page":"789-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of Corneal Neovascularization with a Nutrient Mixture Containing Lysine, Proline, Ascorbic Acid, and Green Tea Extract"],"prefix":"10.1016","volume":"38","author":[{"given":"Yadollah","family":"Shakiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mostafaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.04.006_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization. An epidemiologic review","volume":"433","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","article-title":"Clinical types of corneal transplant rejection their manifestations, frequency, preoperative correlates, and\u00a0treatment","volume":"994","author":"Alldredge","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"124","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib4","first-page":"1954","article-title":"Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization","volume":"3810","author":"Ben Ezra","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment","volume":"230","author":"Crum","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.04.006_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09553009114551601","article-title":"The combination of a bacterial polysaccharide and tamoxifen inhibits angiogenesis and tumour growth","volume":"601\u20132","author":"Tanaka","year":"1991","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00947088","article-title":"Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas","volume":"2359","author":"Murata","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.04.006_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","article-title":"Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization","volume":"646","author":"Kenyon","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib10","first-page":"274","article-title":"Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A","volume":"382","author":"Benelli","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib11","first-page":"228","article-title":"Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization","volume":"952","author":"Huang","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.arcmed.2007.04.006_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ph.49.030187.002321","article-title":"Mechanism of angiogenesis","volume":"49","author":"D'Amore","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1167\/iovs.04-1172","article-title":"Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo","volume":"465","author":"Singh","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor VEGF and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"825","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.arcmed.2007.04.006_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","article-title":"VEGF-dependent conjunctivalization of the corneal surface","volume":"441","author":"Joussen","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib16","first-page":"426","article-title":"Antisense vascular endothelial growth factor suppressed corneal neovascularization in rats","volume":"425","author":"Zhou","year":"2006","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.arcmed.2007.04.006_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02713680500514636","article-title":"Inhibition of ocular angiogenesis by diced small interfering RNAs siRNAs specific to vascular endothelial growth factor VEGF","volume":"312","author":"Murata","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/exer.2002.2075","article-title":"Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA","volume":"756","author":"Lai","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib19","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis","volume":"1656","author":"Kim","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib20","first-page":"203","article-title":"Expression of vascular endothelial growth factor and its receptors flt-1. in morbid human corneas and investigation of its clinic importance","volume":"184","author":"Chen","year":"2002","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.arcmed.2007.04.006_bib21","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"391","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease","volume":"252","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.arcmed.2007.04.006_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"928","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hq0701.093685","article-title":"Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis","volume":"217","author":"Pepper","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000468621","article-title":"Plasminogen activators and matrix metalloproteinases in angiogenesis","volume":"491\u20133","author":"Mignatti","year":"1996","journal-title":"Enzyme Protein"},{"key":"10.1016\/j.arcmed.2007.04.006_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02897-6","article-title":"Diminished corneal angiogenesis in gelatinase A-deficient mice","volume":"5082","author":"Kato","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2007.04.006_bib27","first-page":"955","article-title":"Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis","volume":"434","author":"Zhang","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib28","first-page":"685","article-title":"Corneal burns and matrix metalloproteinases MMP-2 and -9: the effects of human amniotic membrane transplantation","volume":"257","author":"Rigal-Sastourne","year":"2002","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000055693","article-title":"Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization","volume":"336","author":"Ma","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 MMP-2. and vascular endothelial growth factor VEGF in inflammation-associated corneal neovascularization","volume":"704","author":"Kvanta","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2004.08.023","article-title":"Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice","volume":"802","author":"Samolov","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1167\/iovs.02-0180","article-title":"Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice","volume":"441","author":"Berglin","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.arcmed.2007.04.006_bib33","first-page":"943","article-title":"Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786\u2013790","volume":"165","author":"Roomi","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2007.04.006_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/01902140601047658","article-title":"In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549","volume":"329","author":"Roomi","year":"2006","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1385\/MO:23:3:411","article-title":"Effect of ascorbic acid, lysine, proline, and green tea extract on human osteosarcoma cell line MNNG-HOS xenografts in nude mice: evaluation of tumor growth and immunohistochemistry","volume":"233","author":"Roomi","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ijgc-00009577-200605000-00044","article-title":"Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract","volume":"163","author":"Roomi","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.arcmed.2007.04.006_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/01902140600710488","article-title":"Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture","volume":"323","author":"Roomi","year":"2006","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1442-2042.2006.01309.x","article-title":"Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24","volume":"134","author":"Roomi","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/MO:23:1:105","article-title":"In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080","volume":"231","author":"Roomi","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.arcmed.2007.04.006_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1447-0756.2006.00389.x","article-title":"Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract","volume":"322","author":"Roomi","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib41","first-page":"23","article-title":"Natural nutrient mixture effectively reduces collagen matrix contraction driven by human uterine smooth muscle cells","volume":"321","author":"Roomi","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.arcmed.2007.04.006_bib42","first-page":"25","article-title":"In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058","volume":"201","author":"Roomi","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.arcmed.2007.04.006_bib43","first-page":"179","article-title":"In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry","volume":"191","author":"Roomi","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.arcmed.2007.04.006_bib44","first-page":"421","article-title":"In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry","volume":"133","author":"Roomi","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2007.04.006_bib45","first-page":"1399","article-title":"Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells","volume":"146","author":"Roomi","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2007.04.006_bib46","first-page":"807","article-title":"Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis","volume":"144","author":"Roomi","year":"2005","journal-title":"Oncol Rep"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:34:12Z","timestamp":1759260852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0188440907001348"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.04.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Corneal Neovascularization with a Nutrient Mixture Containing Lysine, Proline, Ascorbic Acid, and Green Tea Extract","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}